Takeda - PDFSEARCH.IO - Document Search Engine

Takeda
Results: 516

#	Item
391	Case 1:14-cv[removed]KBJ Document 21 Filed[removed]Page 1 of 30 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DISTRICT OF COLUMBIA TAKEDA PHARMACEUTICALS U.S.A., INC., Add to Reading List Source URL: www.fdalawblog.net Language: English - Date: 2014-10-25 07:58:34 Alkaloids Colchicine Ketones Food and Drug Administration Chemistry Organic chemistry Acetamides
392	Financial Results for FY2012 DATA BOOK Takeda Pharmaceutical Company Limited Add to Reading List Source URL: www.takeda.com Language: English - Date: 2013-05-09 02:01:42 Millennium Pharmaceuticals Takeda Gross profit Pharmacology Health Pharmaceutical sciences Takeda Pharmaceutical Company Pharmaceutical industry
393	SUMMARY OF FINANCIAL STATEMENTS [Japan GAAP] (CONSOLIDATED) Financial Results for the Fiscal Year Ended March 31, 2012 May 11, 2012 Takeda Pharmaceutical Company Limited Add to Reading List Source URL: www.takeda.com Language: English - Date: 2013-05-28 06:09:05 Takeda Pharmaceutical Company Pyridines Thiazolidinediones Pharmaceutical industry Millennium Pharmaceuticals Pioglitazone Nycomed Food and Drug Administration Pharmaceutical sciences Pharmacology Clinical research
394	Ⅳ．Statement of cash flows 　（Billions of Yen） FY08 FY09 Add to Reading List Source URL: www.takeda.com Language: English - Date: 2013-05-28 06:09:07 Financial accounting Cash flow Financial statements Cash flow statement Generally Accepted Accounting Principles Dividend Consolidation Working capital Income Accountancy Finance Business
395	Case 1:14-cv[removed]KBJ Document 73 Filed[removed]Page 1 of 9 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA TAKEDA PHARMACEUTICALS U.S.A., INC. Add to Reading List Source URL: www.fdalawblog.net Language: English - Date: 2015-01-12 12:13:09 Equity Preliminary injunction
396	Takeda Information (Correction) FY2013 Full Year Results “Data Book” This is for filing a correction of the FY2013 full year results “Data Book”, which was published on May 8, 2014, as part of the supplementary m Add to Reading List Source URL: www.takeda.com Language: English - Date: 2014-05-20 04:29:32 Diabetes Dipeptidyl peptidase-4 inhibitor
397	Summary of Financial Statements for the Six Month Period Ended September 30, 2014 (IFRS, Consolidated) October 30, 2014 Takeda Pharmaceutical Company Limited Add to Reading List Source URL: www.takeda.com Language: English - Date: 2014-10-30 01:30:45 Pharmaceutical sciences Organic chemistry Takeda Pharmaceutical Company Pyridines Thiazolidinediones Pharmaceuticals policy Pharmaceutical industry Pioglitazone International Financial Reporting Standards Chemistry Pharmacology Eli Lilly and Company
398	PDF Document Add to Reading List Source URL: www.takeda.com - Date: 2014-10-28 02:19:42
399	Third Quarter of Fiscal 2013 Updates Related to R&D Activities Tsudoi Miyoshi Senior Vice President, Head of CMSO Office February 5, 2014 Add to Reading List Source URL: www.takeda.com Language: English - Date: 2014-02-04 21:55:20 Brentuximab vedotin Japanese yen
400	SUMMARY OF FINANCIAL STATEMENTS [IFRS] (CONSOLIDATED) Financial Results for the Fiscal Year Ended March 31, 2014 May 8, 2014 Takeda Pharmaceutical Company Limited Add to Reading List Source URL: www.takeda.com Language: English - Date: 2014-05-15 04:21:44 Financial statements Pharmacology Takeda Pharmaceutical Company Generally Accepted Accounting Principles International Financial Reporting Standards Pharmaceutical industry Pioglitazone Consolidation Pfizer Accountancy Finance Business

UPDATE